Tuesday, April 21, 2026
34.1 C
New Delhi

Gautam Gambhir, Shubman Gill Not Happy With BCCI – Reason Revealed

Indian head coach Gautam Gambhir and Test captain Shubman Gill have reportedly voiced their displeasure regarding BCCI’s scheduling of the upcoming one-off Test against Afghanistan. The match is set to begin just six days after the conclusion of 2026 IPL final on May 31, leaving the national team with an incredibly narrow window to transition between formats.

IPL 2026 Final is set for May 31, while the one-off Test between India and Afghanistan is scheduled to start on June 6.

Core/regular Test players like Shubman Gill, Jasprit Bumrah, KL Rahul and Ravindra Jadeja are likely to be rested, paving the way for the likes of Gurnoor Brar, Manav Suthar, Auqib Nabi and Devdutt Padikkal – along with a few other in-form domestic performers – to feature in the one-off Test.

The Fatigue Factor

According to a report by the Times of India, both Gambhir and Gill are concerned about the physical toll on multi-format players.

With the IPL final followed immediately by one-off Afghanistan Test, and a white-ball tour of England looming shortly after, the team management is wary of player burnout.

Key regulars, including Gill, Jasprit Bumrah, KL Rahul, and Ravindra Jadeja, face a grueling schedule where they must switch from T20s to Test cricket and then to ODIs – all within a single month.

“There is not much gap between the IPL final and the Afghanistan Test, so the selectors and management will be wary of not burning out the players, as there are three ODIs, then the white-ball series in England.

“There are no WTC points in the Afghanistan Test, and the stakeholders need to carefully manage the workload because some of the players would be on the road for close to two months and have a lot of cricket in the remainder of the year. ODIs and WTC are the priority right now, and you want your best players to be fit, fresh, and available for the four Tests-two vs Sri Lanka and two vs New Zealand-and the many ODIs. Why even risk a Bumrah for this Test?” paper TOI quoted a source as saying.

“And there is little turnaround time between the Test and ODI series. So you will again be in the situation where a Test and ODI regular, say like Gill, Bumrah, KL Rahul, and even Ravindra Jadeja, would switch formats from T20 to Test to ODIs in less than a month’s time. The captain and coach have been very vocal about such scheduling in the past and could have the final say,” the report added.

Potential Squad Changes

Given the lack of World Test Championship (WTC) points at stake for this fixture, the BCCI selectors are considering a “safety-first” approach. To protect core/regular players, the management may opt to field a secondary squad or introduce several “reserve” players to the starting XI.

New Prospects: Emerging talents such as Gurnoor Brar and Devdutt Padikkal are reportedly being monitored as potential inclusions.

Strategic Rotation: The final decision will likely depend on consultations between the coaching staff and the medical team to ensure workload management is prioritized ahead of the high-stakes England series.

The Bottom Line

While BCCI aims to honor international commitments, the vocal opposition from Gambhir and Gill highlights a growing tension between lucrative domestic leagues and the welfare of international stars. With no WTC rankings on the line, the Afghanistan Test may serve as a platform for India’s bench strength rather than a full-strength clinical outing.

Go to Source

Hot this week

Karnataka Home Minister Parameshwara Faces FIR Over Rs 500 Betting Statement

Court orders FIR and probe against Karnataka Home Minister G Parameshwara over his public admission of a 500 rupee kabaddi bet, he calls it a light hearted remark Go to Source Read More

Sydney Sweeney joins ‘Gundam’ live-action cast

Hollywood is gearing up for a live-action ‘Gundam’ film, with ‘Euphoria’ star Sydney Sweeney confirmed for a leading role. She’ll be joined by ‘Harry Potter’ actor Jason Isaacs and Noah Centino. Read More

Trump Tells Iran To Release Women ‘Facing Execution’, Calls It ‘Great Start’ To Talks

Show Quick Read Key points generated by AI, verified by newsroom Trump urges Iran to free eight women facing execution. President asks Iran for no harm in ongoing talks. Read More

‘I’m Sorry For Misleading People’: Tucker Carlson Says He Regrets Backing Trump

Tucker Carlson On Trump: Tucker Carlson went beyond policy criticism and said he personally bore responsibility for helping Trump regain office. Read More

Topics

Karnataka Home Minister Parameshwara Faces FIR Over Rs 500 Betting Statement

Court orders FIR and probe against Karnataka Home Minister G Parameshwara over his public admission of a 500 rupee kabaddi bet, he calls it a light hearted remark Go to Source Read More

Sydney Sweeney joins ‘Gundam’ live-action cast

Hollywood is gearing up for a live-action ‘Gundam’ film, with ‘Euphoria’ star Sydney Sweeney confirmed for a leading role. She’ll be joined by ‘Harry Potter’ actor Jason Isaacs and Noah Centino. Read More

Trump Tells Iran To Release Women ‘Facing Execution’, Calls It ‘Great Start’ To Talks

Show Quick Read Key points generated by AI, verified by newsroom Trump urges Iran to free eight women facing execution. President asks Iran for no harm in ongoing talks. Read More

‘I’m Sorry For Misleading People’: Tucker Carlson Says He Regrets Backing Trump

Tucker Carlson On Trump: Tucker Carlson went beyond policy criticism and said he personally bore responsibility for helping Trump regain office. Read More

Who Is John Ternus? The Man Set To Succeed Tim Cook As Apple CEO

Apple Inc. named John Ternus as its next CEO, with Tim Cook set to move into the role of executive chairman from September 1. Read More

Circus Tiger Leaps Into Crowd In Russia; ‘Remain Calm Or You’ll Make It Worse,’ Trainer Says

Eyewitness video of the tiger roaming the audience area as spectators backed away in fear has gone viral. Read More

Fake Mounjaro Pens Worth Rs 7 Million Seized In India: Here’s How To Identify Counterfeit Drugs

Mounjaro is a popular GLP-1 receptor agonist approved in India for type 2 diabetes and weight management, popularly sold as a weight loss injection among others drugs. Read More

Related Articles